Иммуномодулирующая терапия в комплексном лечении хронического рецидивирующего цистита у женщин

During the period of aggravation 138 women suffer chronic recurrent cystitis was found out immunologicol status, reduction of common population T-lymphocytes(CD3+), T-helpers (CD4+), encrease T-suppressors (CD8+), NK-cells (CD16+), insignificant rise Blymphocyte (CD22+). At same time was found out lowering phagocytosical activity neutrophiles, from all fractions of immunoglobulins For the treatment of the patients group in addition to basic therapy we used immuno-modeing preparation "Immunovit" for the course of the treatment by plan per five grams three times a day per os during 21 day. Research of immunologicol status in the understudied group after treatments made, show standardization indexes of T-lymphocyte (CD3+), T-suppressor (CD8+), rise of T-helper (CD4+) and also level of immunoglobulins IgA and IgG. Effectiveness of present complex therapy consist in recovery of. 80,6% patients of understudied group, in the control group where Immunovit was not used that index was 64,8%. Use of the preparation Immunoit into complex therapy while treatment of chronic recurrent/ cystitis. Standartalize majority of researched clinico-immunological indexes, what at the time givepossibility to reduce treatment period, reduse dose of used antibiotics and the quantity of recurrences.